In MASLD, the liver, being the primary site for angiotensinogen synthesis, experiences increased production and release of angiotensinogen into the bloodstream due to its inflammatory and oxidative stress states. Here, AGT is linked to metabolic dysfunction-associated steatotic liver disease.